Yourgene Health becomes a PacBio compatible partner: Enabling PacBio customers to optimize size selection for long-read sequencing libraries

Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, and PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration to optimize size selection for long-read sequencing workflows. PacBio has qualified Yourgene’s LightBench® instrument for size selection of long DNA fragments, enabling high yields for HiFi sequencing data.

Yourgene’s LightBench is an automated electrophoresis instrument, powered by Ranger® Technology. This platform uses a patent-protected, machine-vision algorithm to interpret and control gel electrophoresis in real time. It delivers accurate size selection for human genomic DNA and includes the ability to perform fragment length analysis for additional quality control.

PacBio HiFi sequencing is a single-molecule real-time (SMRT®) sequencing technology. It produces long (1,000 to 20,000+ bases), accurate reads with uniform genomic coverage and native methylation detection for use in applications such as whole genome reconstruction, haplotype phasing, detection of large and complex variants, and epigenetics.

A new Technical Note was released today for PacBio customers titled “Size selection of PacBio SMRTbell® libraries with the LightBench® instrument from Yourgene Health.” The Yourgene LightBench instrument is compatible with the Revio system. The automated LightBench workflow optimizes walk away time, offering a scalable size selection solution for the preparation of PacBio SMRTbell sequencing libraries. Results from the initial study assessing two fragment lengths in 84 human genomic DNA samples from frozen blood for library preparation showed consistent yields for 8 kb or 10 kb size and a zero percent failure rate.

PacBio HiFi sequencing technology is a game changer for whole genome applications. High-resolution size selection is crucial to maximizing data yields from long-read sequencing and Yourgene is proud to offer researchers a precise and scalable solution with the LightBench.”

Matthew Nesbitt, Co-Founder of Ranger Technology, Yourgene Health

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Yourgene Health. (2023, December 13). Yourgene Health becomes a PacBio compatible partner: Enabling PacBio customers to optimize size selection for long-read sequencing libraries. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20231122/Yourgene-Health-becomes-a-PacBio-compatible-partner-Enabling-PacBio-customers-to-optimize-size-selection-for-long-read-sequencing-libraries.aspx.

  • MLA

    Yourgene Health. "Yourgene Health becomes a PacBio compatible partner: Enabling PacBio customers to optimize size selection for long-read sequencing libraries". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20231122/Yourgene-Health-becomes-a-PacBio-compatible-partner-Enabling-PacBio-customers-to-optimize-size-selection-for-long-read-sequencing-libraries.aspx>.

  • Chicago

    Yourgene Health. "Yourgene Health becomes a PacBio compatible partner: Enabling PacBio customers to optimize size selection for long-read sequencing libraries". News-Medical. https://www.news-medical.net/news/20231122/Yourgene-Health-becomes-a-PacBio-compatible-partner-Enabling-PacBio-customers-to-optimize-size-selection-for-long-read-sequencing-libraries.aspx. (accessed November 21, 2024).

  • Harvard

    Yourgene Health. 2023. Yourgene Health becomes a PacBio compatible partner: Enabling PacBio customers to optimize size selection for long-read sequencing libraries. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20231122/Yourgene-Health-becomes-a-PacBio-compatible-partner-Enabling-PacBio-customers-to-optimize-size-selection-for-long-read-sequencing-libraries.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Improving COVID-19 diagnosis